Search results
Cranbury Pharmaceuticals Receives FDA Approval for First Generic Version of Emflaza Oral Suspension
New Jersey Business Magazine· 13 hours agoCranbury Pharmaceuticals, a wholly-owned subsidiary of Tris Pharma, today announced the U.S. Food...
Supreme Court rejects bid to restrict access to abortion pill
NBC News via Yahoo News· 1 hour agoAbortion is effectively banned altogether in 14 states, according to the Guttmacher Institute, a...
The Latest | The US Supreme Court rules to preserve access to the abortion pill mifepristone
Associated Press via Yahoo News· 5 hours agoThe U.S. Supreme Court on Thursday ruled unanimously to preserve access to the drug most commonly...
Supreme court rejects case that would have curbed access to abortion drug
Medical Xpress· 2 hours agoIn a unanimous vote, the nine judges ruled that a group of doctors and other medical...
Leo’s single-dose autoinjector secures FDA approval for atopic dermatitis
Pharmaceutical Technology via Yahoo Finance· 4 hours agoAccording to GlobalData’s analysts, atopic dermatitis presents a mine of opportunities, particularly...
Supreme Court rules in abortion medication case, finds group lacked standing to challenge FDA...
Fox News via Yahoo News· 6 hours agoThe Supreme Court on Thursday ruled that challengers the FDA's approval process of the abortion drug...
FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Pharmaceutical Technology via Yahoo Finance· 11 hours agoThe latest development comes after AstraZeneca‘s supplemental new drug application for Tagrisso...
Supreme Court rejects challenge to FDA's approval of mifepristone
NPR· 6 hours agoDr. Jeremy Levin, the CEO of Ovid Therapeutics, one of the many pharmaceutical companies that sided...
Supreme Court Backs Full Access to Widely Used Abortion Pill
Bloomberg via Yahoo News· 2 hours ago(Bloomberg) -- The US Supreme Court preserved full access to a widely used abortion pill in a case...
Ultragenyx wins surrogate endpoint debate, securing green light to seek FDA approval of gene therapy
FierceBiotech· 10 hours agoUltragenyx Pharmaceutical's work to get the FDA to recognize a biomarker as a surrogate endpoint looks to have paid off. With the agency agreeing the biomarker ...